Literature DB >> 6796105

Renal conversion of plasma DOPA to urine dopamine.

M J Brown, D J Allison.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6796105      PMCID： PMC1401852          DOI： 10.1111/j.1365-2125.1981.tb01210.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Dopamine-containing vasomotor nerves in the dog kidney.

Authors:  C Bell; W J Lang; F Laska
Journal:  J Neurochem       Date:  1978-07       Impact factor: 5.372

2.  The effect of mineralocorticoid administration on urine free dopamine in man.

Authors:  N S Oates; C M Perkins; M R Lee
Journal:  Clin Sci (Lond)       Date:  1980-01       Impact factor: 6.124

3.  A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine.

Authors:  M J Brown; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335
  3 in total
  8 in total

1.  Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma.

Authors:  Graeme Eisenhofer; Karel Pacak; Thanh-Truc Huynh; Nan Qin; Gennady Bratslavsky; W Marston Linehan; Massimo Mannelli; Peter Friberg; Stefan K Grebe; Henri J Timmers; Stefan R Bornstein; Jacques W M Lenders
Journal:  Endocr Relat Cancer       Date:  2010-12-21       Impact factor: 5.678

2.  The pharmacokinetics of gamma-glutamyl-L-dopa in normal and anephric rats and rats with glycerol-induced acute renal failure.

Authors:  Y A Boateng; H E Barber; T M MacDonald; J C Petrie; M R Lee; P H Whiting
Journal:  Br J Pharmacol       Date:  1990-10       Impact factor: 8.739

3.  Dopaminergic control of renal tubular function in patients with compensated cirrhosis.

Authors:  Giovanni Sansoè; Alberto Ferrari; Enrica Baraldi; Carmen Nives Castellana; Alessandra Biava; Stefano Silvano; Floriano Rosina; Lorenzo Bonardi; Federico Manenti
Journal:  Dig Dis Sci       Date:  2002-02       Impact factor: 3.199

4.  Disposition of gamma-glutamyl levodopa (gludopa) after intravenous bolus injection in healthy volunteers.

Authors:  Y A Boateng; H E Barber; T M MacDonald; J C Petrie; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

5.  The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man.

Authors:  R F Jeffrey; T M MacDonald; K Marwick; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

6.  Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.

Authors:  Dipti Rao; Mirko Peitzsch; Aleksander Prejbisz; Katarzyna Hanus; Martin Fassnacht; Felix Beuschlein; Christina Brugger; Stephanie Fliedner; Katharina Langton; Christina Pamporaki; Volker Gudziol; Anthony Stell; Andrzej Januszewicz; Henri J L M Timmers; Jacques W M Lenders; Graeme Eisenhofer
Journal:  Eur J Endocrinol       Date:  2017-05-05       Impact factor: 6.664

Review 7.  Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma.

Authors:  Graeme Eisenhofer; Mirko Peitzsch; Nicole Bechmann; Angela Huebner
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-26       Impact factor: 6.055

Review 8.  Personalized Management of Pheochromocytoma and Paraganglioma.

Authors:  Svenja Nölting; Nicole Bechmann; David Taieb; Felix Beuschlein; Martin Fassnacht; Matthias Kroiss; Graeme Eisenhofer; Ashley Grossman; Karel Pacak
Journal:  Endocr Rev       Date:  2022-03-09       Impact factor: 19.871
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.